TOE1 activators are a group of compounds that, through various mechanisms, can upregulate the expression or activity of the Target of EGR1, protein 1 (TOE1). TOE1 is a multifunctional protein implicated in RNA processing and cellular signaling pathways. Activators in this class may function through direct interaction with the TOE1 protein, influencing its stability or activity, or they may operate indirectly by modulating the cellular environment or signaling pathways that control the transcriptional regulation of the TOE1 gene. The direct activators might bind to TOE1, altering its conformation in a way that enhances its functional activity or prevents its degradation, thereby increasing its presence and action within the cell. Indirect activators, on the other hand, could affect the transcription factors or epigenetic markers that govern TOE1 gene expression, leading to a higher production of TOE1 protein.
The indirect activators encompass a wide range of compounds that could influence TOE1 expression by targeting various upstream regulators. This could include small molecules that modulate signal transduction pathways, such as kinase inhibitors or agonists that impact cellular stress responses, ultimately leading to the upregulation of TOE1. These activators could function by altering phosphorylation states of key signaling molecules, changing the redox state of the cell, or modulating the activity of transcription factors directly involved in TOE1 gene expression. Additionally, compounds that affect the chromatin state, such as histone deacetylase inhibitors or DNA methyltransferase inhibitors, could cause changes in the accessibility of the TOE1 gene to the transcriptional machinery, resulting in increased TOE1 expression.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
It may modulate gene expression through retinoic acid receptors, potentially affecting TOE1 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
It elevates cAMP levels, which may activate protein kinase A and influence transcription factors affecting TOE1 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
It activates protein kinase C which could lead to changes in gene expression, including TOE1. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
This estrogen could interact with estrogen receptors and affect gene expression patterns, possibly including TOE1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, potentially altering transcription factor activity and influencing TOE1 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
This p38 MAP kinase inhibitor may change the activity of transcription factors that regulate TOE1 expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
It can inhibit GSK-3 leading to Wnt pathway activation, which may in turn upregulate TOE1 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
As an HDAC inhibitor, it can affect chromatin remodeling and possibly increase TOE1 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
This polyphenol may affect numerous signaling pathways, potentially modulating TOE1 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
It induces ER stress which can lead to the activation of the unfolded protein response, possibly affecting TOE1 expression. |